Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unresolved hemostasis issues in haemophilia.
Sidonio RF Jr, Weisel JW, Stafford D. Sidonio RF Jr, et al. Haemophilia. 2024 Apr;30 Suppl 3:70-77. doi: 10.1111/hae.14999. Epub 2024 Apr 4. Haemophilia. 2024. PMID: 38575518
Procedural outcomes in children with mild type 1 von Willebrand disease.
Heery S, Zimowski K, Mason SF, White MH, DiGiandomenico S, Trotter C, Sidonio RF Jr, Brown MC. Heery S, et al. Among authors: sidonio rf jr. Res Pract Thromb Haemost. 2024 Feb 2;8(1):102334. doi: 10.1016/j.rpth.2024.102334. eCollection 2024 Jan. Res Pract Thromb Haemost. 2024. PMID: 38440264 Free PMC article.
Patient-centred research agenda for females with bleeding disorders.
Crescioni M, Armijo W, Chupka J, Tarver D, Sidonio R Jr, Brown MC, Haley KM, Huguelet P, Bowe-Hause K, Conde J, Johnson S, Iftikhar A, Lerman C. Crescioni M, et al. Among authors: sidonio r jr. Haemophilia. 2023 Nov;29(6):1665-1667. doi: 10.1111/hae.14883. Epub 2023 Oct 18. Haemophilia. 2023. PMID: 37850819 No abstract available.
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study.
Sidonio RF Jr, Thompson AA, Peyvandi F, Stasyshyn O, Yeoh SL, Sosothikul D, Antmen AB, Maggiore C, Engl W, Ewenstein B, Tangada S. Sidonio RF Jr, et al. Expert Rev Hematol. 2023 Jul-Dec;16(10):793-801. doi: 10.1080/17474086.2023.2247160. Epub 2023 Sep 7. Expert Rev Hematol. 2023. PMID: 37646148
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Ragni MV, Rothenberger SD, Feldman R, Nance D, Leavitt AD, Malec L, Kulkarni R, Sidonio R Jr, Kraut E, Lasky J, Pruthi R, Angelini D, Philipp C, Hwang N, Wheeler AP, Seaman C, Machin N, Xavier F, Meyer M, Bellissimo D, Humphreys G, Smith KJ, Merricks EP, Nichols TC, Ivanco D, Vehec D, Koerbel G, Althouse AD. Ragni MV, et al. Among authors: sidonio r jr. Lancet Haematol. 2023 Aug;10(8):e612-e623. doi: 10.1016/S2352-3026(23)00119-9. Epub 2023 Jun 26. Lancet Haematol. 2023. PMID: 37385272 Clinical Trial.
68 results